BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5170447)

  • 1. Quantitative assay of a protein antigen of vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    Aust J Exp Biol Med Sci; 1971 Dec; 49(6):605-12. PubMed ID: 5170447
    [No Abstract]   [Full Text] [Related]  

  • 2. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of vibrio cholerae virulence. II. Skin permeability factor-cholera enterotoxin production in a chemically defined medium.
    Callahan LT; Ryder RC; Richardson SH
    Infect Immun; 1971 Nov; 4(5):611-8. PubMed ID: 5170548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 7. Vibriocidal test and its parameters.
    Ganguly R; Deb BC; Shrivastava DL
    Indian J Med Res; 1969 May; 57(5):815-22. PubMed ID: 5820430
    [No Abstract]   [Full Text] [Related]  

  • 8. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX.
    Barua D; Watanabe Y
    J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
    Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
    J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical studies on lipopolysaccharide from agglutinable and non-agglutinable vibrios.
    Guhathakurta B; Dutta GC
    Appl Microbiol; 1974 Apr; 27(4):634-9. PubMed ID: 4207760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cellular structures of cholera and non-cholera vibrios in the development of non-specific resistance].
    Zykin LF; Petrova LS
    Antibiotiki; 1970 Jun; 15(6):537-40. PubMed ID: 5458636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of exotoxins and endotoxins of cholera-like vibrions using the immunoelectrophoretic method and gel precipitation reaction].
    Vvedenskaia OI; Givental' NI; Ermol'eva ZV
    Antibiotiki; 1972 Jul; 17(7):602-7. PubMed ID: 4655010
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agglutinating and bactericidal properties of fractions of rabbit anti-Vibrio cholerae serum.
    Pike RM; Chandler CH
    J Bacteriol; 1969 Jun; 98(3):956-62. PubMed ID: 5788722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibriocidal activity, immune globulin producing cells and immune globulin levels in Theropithecus gelada after administration of a vibrio cholerae antigen.
    Felsenfeld O; Greer WE
    Immunology; 1968 Mar; 14(3):319-24. PubMed ID: 4170509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera antitoxin titrations: a comparative study of fat-cell, ileal-loop, and rabbit-skin assays.
    Curlin CT; Mosley WH; Greenough WB
    J Infect Dis; 1973 Mar; 127(3):294-8. PubMed ID: 4734668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cell envelopes and lipopolysaccharides of gram-negative bacteria (author's transl)].
    Kawata T; Hisatsune K
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():229-43. PubMed ID: 800276
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation of protective bacterial substances against experimental vibrio infection.
    Yoshioka M; Takahashi K; Hirano T; Kazuno Y; Takeuchi S; Akiba Y; Ghoda A; Suzuki T; Suzuki Y
    J Infect Dis; 1970 May; 121():Suppl 121:45+. PubMed ID: 5421428
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipopolysaccharides of non-cholera vibrios possessing common antigen factor to 01 Vibrio cholerae.
    Hisatsune K; Haishima Y; Iguchi T; Kondo S
    Adv Exp Med Biol; 1990; 256():189-97. PubMed ID: 2327294
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of vibriocidal antibodies with regard to immunity to cholera.
    Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR
    J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.